15 Stocks That Outperform the S&P 500 Every Year For the Last 3 Years

2. Hims & Hers Health, Inc. (NYSE:HIMS)

3-Year Return as of the Close of March 12: 656%

Hims & Hers Health, Inc. (NYSE:HIMS) is a leading telehealth platform that connects consumers to professional healthcare providers in the USA, UK, and internationally. On a mission to normalize health and wellness challenges, and innovate solutions, the company offers a range of curated prescription and nonprescription health and wellness products and services via its website and mobile application. This California-based company also provides medical consultation and post-consultation support services to enhance the overall well-being of all.

Considering the company’s Q4 financials, HIMS bid farewell to 2024 with 2.2M subscribers, reflecting a year-over-year surge of 45%. On a quarter basis, it welcomed 182K net new subscribers, which ranks as the second highest in a single quarter. The management attributes this growth to the expansion of personalized treatments, from unique form factors and multi-condition treatments to tailored dosages. While the addition of subscribers strengthens the platform in terms of brand loyalty, data insights, product innovation, and clinical experience, it also tells the future.

Hims & Hers Health, Inc. (NYSE:HIMS) recently launched a weight-loss portfolio, which was met with huge success. The offerings, which include oral weight loss and compounded GLP-1 injections, not only increased revenues but also secured the company’s position in entering new specialties and scale. That being said, management expects the revenue through its weight loss segment to be at least $725 million in 2025.

Looking ahead, the company has projected revenues between $2.3 billion and $2.4 billion for the current year, with adjusted EBITDA to expand from $177 million to a range of $270-320 million in 2025. Delivering a return of over 676% in the last three years, Hims & Hers Health, Inc. (NYSE:HIMS) has outperformed the health sector.